Study Evaluating Safety Of Patients Switching To ReFacto AF In Usual Care Settings

PHASE4TerminatedINTERVENTIONAL
Enrollment

208

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Hemophilia A
Interventions
DRUG

moroctocog alfa (AF-CC) (ReFacto AF)

Providing moroctocog alfa (AF-CC) as test article for use during this study.

PROCEDURE

Laboratory tests

Laboratory samples are collected during study visits, in order to collect safety and efficacy data related to the administration of test article.

Trial Locations (74)

1020

Pfizer Investigational Site, Brussels

1090

Pfizer Investigational Site, Vienna

1134

Pfizer Investigational Site, Budapest

1200

Pfizer Investigational Site, Brussels

2100

Pfizer Investigational Site, Copenhagen

3000

Pfizer Investigational Site, Leuven

4009

Pfizer Investigational Site, Almería

10003

Pfizer Investigational Site, Cáceres

10015

Pfizer Investigational Site, Ivrea

10249

Pfizer Investigational Site, Berlin

11300

Pfizer Investigational Site, Cadiz

11510

Pfizer Investigational Site, Puerto Real

11527

Pfizer Investigational Site, Athens

13385

Pfizer Investigational Site, Marseille

15006

Pfizer Investigational Site, A Coruña

17176

Pfizer Investigational Site, Stockholm

18012

Pfizer Investigational Site, Granada

18059

Pfizer Investigational Site, Rostock

20122

Pfizer Investigational Site, Milan

20246

Pfizer Investigational Site, Hamburg

27100

Pfizer Investigational Site, Pavia

28046

Pfizer Investigational Site, Madrid

28177

Pfizer Investigational Site, Bremen

29010

Pfizer Investigational Site, Málaga

29011

Pfizer Investigational Site, Málaga

31033

Pfizer Investigational Site, Treviso

33100

Pfizer Investigational Site, Udine

34295

Pfizer Investigational Site, Montpellier

36043

Pfizer Investigational Site, Fulda

37170

Pfizer Investigational Site, Chambray-lès-Tours

39112

Pfizer Investigational Site, Magdeburg

41345

Pfizer Investigational Site, Gothenburg

44093

Pfizer Investigational Site, Nantes

46009

Pfizer Investigational Site, Valencia

47012

Pfizer Investigational Site, Valladolid

48143

Pfizer Investigational Site, Münster

50009

Pfizer Investigational Site, Zaragoza

50134

Pfizer Investigational Site, Florence

53127

Pfizer Investigational Site, Bonn

60596

Pfizer Investigational Site, Frankfurt am Main

63003

Pfizer Investigational Site, Clermont-Ferrand

65191

Pfizer Investigational Site, Wiesbaden

66421

Pfizer Investigational Site, Homburg

69123

Pfizer Investigational Site, Heidelberg

69437

Pfizer Investigational Site, Lyon

70176

Pfizer Investigational Site, Stuttgart

70211

Pfizer Investigational Site, Kuopio

75743

Pfizer Investigational Site, Paris

78157

Pfizer Investigational Site, Le Chesnay

80131

Pfizer Investigational Site, Napoli

80336

Pfizer Investigational Site, München

80337

Pfizer Investigational Site, München

87042

Pfizer Investigational Site, Limoges

94275

Pfizer Investigational Site, Le Kremlin-Bicêtre

95160

Pfizer Investigational Site, Montmorency

00029 HUS

Pfizer Investigational Site, Helsinki

01307

Pfizer Investigational Site, Dresden

06120

Pfizer Investigational Site, Halle

04103

Pfizer Investigational Site, Leipzig

04289

Pfizer Investigational Site, Leipzig

06156

Pfizer Investigational Site, Perugia

1105 AZ

Pfizer Investigational Site, Amsterdam

9713 GZ

Pfizer Investigational Site, Groningen

3584 CX

Pfizer Investigational Site, Utrecht

011155

Pfizer Investigational Site, Bucharest

05004

Pfizer Investigational Site, Ávila

07010

Pfizer Investigational Site, Palma de Mallorca

08035

Pfizer Investigational Site, Barcelona

205 02

Pfizer Investigational Site, Malmo

B4 6NH

Pfizer Investigational Site, Birmingham

NW3 2QG

Pfizer Investigational Site, London

EH3 9YW

Pfizer Investigational Site, Edinburgh

LL57 2PW

Pfizer Investigational Site, Bangor

M13 9WL

Pfizer Investigational Site, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY